AC133 antigen as a prognostic factor in acute leukemia

Leukemia Research

Volumn 25, Issue 9, 2001, Pages 757-767

  Tae Lee, Seung ^a   Ho Jang, Joon ^a   Hong Min, Yoo ^a   Sook Hahn, Jee ^a   Woong Ko, Yun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

AC133 antigen; Acute leukemia; Prognosis

Indexed keywords

ALLOANTIGEN; BETA1 INTEGRIN; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD62E ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR4; ENDOGLIN; L SELECTIN; LACTATE DEHYDROGENASE; LEUKEMIA ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; STAINING; SURVIVAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; DISEASE PROGRESSION; FEMALE; GLYCOPROTEINS; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PEPTIDES; PROGNOSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0034899224     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00016-9     Document Type: Article

References (29)

1. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning
2. AC133, a novel marker for human hematopoietic stem and progenitor cells
3. Expression of the AC133 antigen in leukemic and normal progenitors
4. + B-cell precursors
5. Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells
6. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML
7. CD34 expression in adult acute lymphoblastic leukemia
8. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia
9. Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts
10. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases
11. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia
12. Expression of alpha4-integrin defines the earliest precursor of hematopoietic cell lineage diverged from endothelial cells
13. + haemopoietic progenitors
14. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
15. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate
16. Interaction of acute leukemia cells with the bone marrow microenvironment: Implications for control of minimal residual disease
17. Beta-1-integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34
18. Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages
19. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia
20. Differential expression of adhesion molecules in acute leukemia
21. Expression of VLA molecules on acute leukemia cells: Relationship with disease characteristics
22. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia
23. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells
24. Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia
25. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
26. + progenitors to peripheral blood
27. High levels of the shed form of l-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium
28. + cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31)
29. Acute myeloid leukaemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1)